DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

| Source: EQS Group AG EQS Group AG 

STADA Arzneimittel AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)

12.03.2009 

Release of a Voting Rights announcement
---------------------------------------------------------------------------


On 03 March, 2009 Deutsche Bank AG London, London, Great Britain, notified
STADA Arzneimittel AG, Bad Vilbel, Germany, ISIN DE 0007251803, pursuant to
section 21 (1) WpHG ('German Securities Trading Act') of the following:

Pursuant to section 21 (1), 24 WpHG ('German Securities Trading Act') in
conjuction with section 32 (2) InvG ('German Investment Act'), Deutsche
Bank London, London, Great Britain, notifed that the percentage of voting
rights of its subsidiary DWS Investment GmbH, Frankfurt, Germany, in STADA
Arzneimittel AG, Bad Vilbel, Germany, crossed below the threshold of 3 % on
09 March 2009 and amounts to 2.44 % (1,432,500 voting rights) as per this
date.

DGAP 12.03.2009 
---------------------------------------------------------------------------
Language:     English
Issuer:       STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Deutschland
Internet:     www.stada.de
End of News                                     DGAP News-Service
---------------------------------------------------------------------------